加速康复路径对胃食管与肝胆胰手术费用及围术期结局的影响
该研究在学术机构内评估前瞻性实施的加速康复外科(ERAS)路径对胃食管与肝胆胰手术患者的影响。377例患者中149例进入ERAS路径,结果显示ERAS与围术期抗生素使用增加、术中晶体液用量减少、ICU入住需求下降及总住院费用降低相关,多因素分析中ERAS独立关联ICU入住率降低。
要点
- ERAS路径可安全用于肝胆胰与胃食管手术患者
- ERAS与ICU入住需求下降及总住院费用降低相关
- ERAS组术中晶体液用量更少、围术期抗生素使用比例更高
核心结论
- 在肝胆胰与胃食管手术患者中,ERAS路径可安全实施,有助于标准化围术期实践、降低ICU入住需求并降低总住院费用。
研究设计与样本
- 单中心学术机构研究,纳入2013年1月至2017年5月接受肝胆胰或胃食管手术的患者,按是否进入前瞻性实施的ERAS路径分组,比较人口学、围术期、结局与财务变量,共377例,其中149例进入ERAS路径。
主要发现
- ERAS组围术期抗生素使用比例为98.0%,非ERAS组为87.3%(P < .001)。
- ERAS组术中晶体液用量为1,155 ± 705 mL,非ERAS组为1,576 ± 826 mL(P < .001)。
- ERAS组ICU入住率为20.1%,非ERAS组为36.4%(P < .001)。
- ERAS组总住院费用为$10,688.38 ± 10,518.22,非ERAS组为$15,439.22 ± 14,201.24(P < .001)。
- 多因素分析中ERAS路径使用独立关联ICU入住率降低(OR 0.39,95%CI 0.23-0.66,P < .001)。
临床怎么用
- 在肝胆胰与胃食管手术患者中可安全推行ERAS路径,以标准化围术期管理并降低ICU入住需求与总住院费用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Enhanced recovery after surgery protocols have been increasingly adopted to standardize patient care and decrease overall costs. This study evaluated the impact of a prospectively implemented enhanced recovery after surgery protocol for patients undergoing surgery for gastroesophageal and hepatopancreatobiliary disease at an academic institution. METHODS: Patients undergoing either hepatopancreatobiliary or gastroesophageal procedures between January 2013 and May 2017 were classified according to whether or not they were placed on an enhanced recovery after surgery protocol. Groups were compared along demographic, perioperative, outcomes, and financial variables. RESULTS: Of a total of 377 patients, 149 were placed on an enhanced recovery after surgery protocol. There was a significant association between enhanced recovery after surgery protocol use and increased perioperative antibiotic use (98.0% enhanced recovery after surgery vs. 87.3% non-enhanced recovery after surgery, P < .001), decreased intraoperative crystalloid use (1,155 ± 705 mL enhanced recovery after surgery vs. 1,576 ± 826 non-enhanced recovery after surgery, P < .001), decreased requirement for intensive care unit stay (20.1% enhanced recovery after surgery vs. 36.4% non-enhanced recovery after surgery, P < .001), and decreased total hospital costs ($10,688.38 ± 10,518.22 vs. $15,439.22 ± 14,201.24, P < .001). On multivariable analysis, enhanced recovery after surgery protocol use was independently associated with decreased rate of intensive care unit admission (odds ratio 0.39, 95% confidence interval 0.23-0.66, P < .001). CONCLUSION: Enhanced recovery after surgery pathways can be safely implemented in patients undergoing hepatopancreatobiliary and gastroesophageal procedures and can help standardize perioperative practices, decrease requirement for intensive care unit admission, and decrease total hospital costs.
引用
- Bhutiani N, Quinn SA, Jones JM, et al. The impact of enhanced recovery pathways on cost of care and perioperative outcomes in patients undergoing gastroesophageal and hepatopancreatobiliary surgery. Surgery. 2018. PMID: 30072252. doi:10.1016/j.surg.2018.05.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。